BEIJING, June 15, 2018 /PRNewswire/ -- JA Solar Holdings Co., Ltd. (Nasdaq: JASO), a world leading manufacturer of high-performance solar power products, today announced that it was awarded the "2018 Top Performer" by DNV GL, a world renowned independent energy experts and certification...
JA Solar Named "Top Performer" by DNV GL for the Third Time
↧
↧
Dorian LPG Board Declines BW LPG'S Unsolicited Proposal
STAMFORD, Conn., June 15, 2018 /PRNewswire/ -- Dorian LPG Ltd. (NYSE: LPG) ("Dorian" or the "Company") today announced that its Board of Directors has unanimously declined an unsolicited, conditional proposal from BW LPG Ltd. (OB: BWLPG) ("BW LPG") to combine with Dorian in a...
↧
Smart Cannabis Corp. Retrofits and Automates Greenhouses in Monterey County, Shares Update on LOIs for SAP Investments
SACRAMENTO, Calif., June 15, 2018 /PRNewswire/ -- Smart Cannabis Corp. (OTC: SCNA) announced that its subsidiary, Next Generation Farming, has completed retrofitting ten (10) greenhouses at a Monterey County cultivation facility.
In phase one of the agreement, Next Generation...
↧
Blockchain Leveraging Full Benefits of Distributed Ledger Technology for Growing Number of Markets
PALM BEACH, Florida, June 15, 2018 /PRNewswire/ --
MarketNewsUpdates.com News Commentary
Blockchain is disrupting so much more than the data management industry. Peer-to-peer networks are infusing the infrastructure of cryptography which is generating a growing demand in...
↧
Denison Consulting Group Offers First-of-its-Kind Cloud-Based Managed Services for Global Manufacturers
CARLISLE, Pa., June 15, 2018 /PRNewswire/ -- Denison Consulting Group today announces general availability of their first-to-market, industry-leading managed service to support how global manufacturers measure and manage energy and power quality - two of the largest cost drivers in the...
↧
↧
MGM Growth Properties LLC Completes Increase and Extension of Term Loan A and Revolver Through Amended Credit Facilities
LAS VEGAS, June 15, 2018 /PRNewswire/ -- MGM Growth Properties LLC (NYSE: MGP) (the "Company") today announced that it has successfully amended its operating partnership's credit agreement to provide for a $750 million increase and extension of the revolving facility to $1,350 million due...
↧
RapidOps Celebrates 10-Year Anniversary of High-Technology Product Development Solutions
CHARLOTTE, N.C., June 16, 2018 /PRNewswire/ -- RapidOps Inc. today announced its 10-year anniversary celebration in May 2018, as it looks back on the many worldwide clients served and also looks ahead to its next 10 years partnering with clients to build and deploy award-winning software...
↧
Association européenne d'hématologie : une nouvelle immunothérapie à cellules CAR-T anti-CD22 sauve la vie d'enfants atteints de leucémie
STOCKHOLM, June 16, 2018 /PRNewswire/ --
La leucémie aiguë lymphoblastique B (LAL-B) est un cancer hématologique mortel généralement traité par chimiothérapie ou allogreffe de cellules souches hématopoïétiques (allo-CSH), et la thérapie cellulaire CD19-CAR-T s'est avérée efficace dans...
↧
Ibrutinib más Rituximab para pacientes con macroglobulinemia de Waldenström
ESTOCOLMO, June 16, 2018 /PRNewswire/ --
- Asociación Europea de Hematología: Estudio iNNOVATE:Ibrutinib más Rituximab para pacientes con macroglobulinemia de Waldenström
(Logo: http://mma.prnewswire.com/media/622259/EHA_Logo.jpg )
La macroglobulinemia de Waldens...
↧
↧
Association européenne d'hématologie : répondre aux besoins non satisfaits de l'un des types de lymphomes les plus répandus : simple comme C-A-M
STOCKHOLM, June 16, 2018 /PRNewswire/ --
Le lymphome diffus à grandes cellules B (LDGCB) est le type de lymphome non hodgkinien le plus répandu. Malheureusement, 40 % des patients rechutent ou ne réagissent pas au traitement initial, ce qui entraîne de mauvais pronostics,...
↧
Europäischer Hämatologenverband: neue Anti-CD22 CAR-T-Immuntherapie rettete das Leben von Kindern mit Leukämie
STOCKHOLM, June 15, 2018 /PRNewswire/ --
B akute lymphoblastische Leukämie (B-ALL) ist eine tödliche Blutkrebsart, die in der Regel mit Chemotherapie oder einer allogenen hämatopoetischen Stammzelltransplantation (allo-HCT) behandelt wird. Die CD19-CAR-T-Zelltherapie wurde erfolgreich...
↧
Association européenne d'hématologie : étude iNNOVATE : combinaison ibrutinib-rituximab pour le traitement des patients atteints de macroglobulinémie de Waldenström
STOCKHOLM, June 16, 2018 /PRNewswire/ --
La macroglobulinémie de Waldenström (MW) est un type de cancer hématologique rare. Comme la MW est rare, il est difficile de mener des études cliniques de grande ampleur et de déterminer un traitement standard pour cette maladie. Le rituximab,...
↧
Europäischer Hämatologenverband: iNNOVATE-Studie - Ibrutinib plus Rituximab für Patienten mit Morbus Waldenström
STOCKHOLM, June 16, 2018 /PRNewswire/ --
Morbus Waldenström (WM, auch Waldenströms Makroglobulinämie genannt) ist eine seltene Art von Blutkrebs. Da es sich um eine seltene Krankheit handelt, ist es nicht einfach, große klinische Studien durchzuführen, um eine Standardbehandlung...
↧
↧
Europäischer Hämatologenverband: die Antwort auf den ungedeckten Bedarf für eine der verbreitetsten Arten von Lymphom ist ... schlicht und einfach A-D-C
STOCKHOLM, June 16, 2018 /PRNewswire/ --
Das diffus großzellige B-Zell-Lymphom (DLBCL) ist die häufigste Art von Non-Hodgkin-Lymphom. Leider erleiden 40 % der Patienten Rückfälle oder sprechen nicht auf die Erstbehandlung an, und dies bedeutet schlechte Prognosen, besonders für...
↧
European Hematology Association: Una nueva inmunoterapia anti-CD22 CAR-T salva la vida de un niño con leucemia
ESTOCOLMO, June 16, 2018 /PRNewswire/ --
La leucemia linfoblástica aguda B (B-ALL) es un tumor mortal de los glóbulos que normalmente se trata con quimioterapia o transplante de células de tallo hematopoyéticas (allo-HCT), y la terapia celular CD19-CAR-T ha conseguido el éxito en el...
↧
European Hematology Association: iNNOVATE Study: Ibrutinib Plus Rituximab for Patients With Waldenström's Macroglobulinemia
STOCKHOLM, June 16, 2018 /PRNewswire/ --
Waldenström's Macroglobulinemia (WM) is a rare type of blood cancer. Since WM is rare, it is difficult to conduct large clinical studies and determine a standard treatment for the disease. Rituximab, a therapy used to treat other types of blood...
↧
European Hematology Association: Answering the Unmet Need in One of the Most Common Types of Lymphoma: It's as Simple as A-D-C
STOCKHOLM, June 16, 2018 /PRNewswire/ --
Diffuse large B-cell lymphoma (DLBCL) is the most common type of non-Hodgkin lymphoma. Unfortunately, 40% of patients will relapse after or not respond to initial treatment resulting in poor outcomes especially if stem cell transplant is not an...
↧
↧
European Hematology Association:Dando respuesta a la necesidad no cumplida en uno de los tipos de linfoma más comunes
ESTOCOLMO, June 16, 2018 /PRNewswire/ --
European Hematology Association:Dando respuesta a la necesidad no cumplida en uno de los tipos de linfoma más comunes:Tan sencillo como A-D-C
El linfoma difuso de células B grandes (DLBCL) es el tipo más común de linfoma...
↧
European Hematology Association: A New Anti-CD22 CAR-T Immunotherapy Saved Life of Children With Leukemia
STOCKHOLM, June 16, 2018 /PRNewswire/ --
B acute lymphoblastic leukemia (B-ALL) is a fatal blood cell tumor that is usually treated with chemotherapy or allogeneic hematopoietic stem cell transplantation (allo-HCT), and CD19-CAR-T cell therapy has been successful in treating...
↧
Vivo eröffnet die Feier zum 2018 FIFA World Cup(TM) mit Stil
Die globale Smartphone-Marke Vivo bleibt ihrer Linie „Kamera und Musik" beim 2018 FIFA World Cup Russia™ treu und inspiriert im Luzhniki-Stadion mit wichtigen neuen Funktionen
MOSKAU, 16. Juni 2018 /PRNewswire/ -- Der mit viel Spannung erwartete 2018 FIFA World Cup Russia™ hat...
↧
More Pages to Explore .....
